Lv11
46 积分 2025-04-09 加入
Differential Response of MDA-MB-231 and MCF-7 Breast Cancer Cells to In Vitro Inhibition with CTLA-4 and PD-1 through Cancer-Immune Cells Modified Interactions
6小时前
已关闭
An organoid co-culture model for probing systemic anti-tumor immunity in lung cancer
3天前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
4天前
已完结
Ivonescimab plus chemotherapy versus tislelizumab plus chemotherapy as first-line treatment for advanced squamous non-small-cell lung cancer (HARMONi-6): a randomised, double-blind, phase 3 trial
4天前
已完结
Multimodal targeting chimeras enable integrated immunotherapy leveraging tumor-immune microenvironment
4天前
已完结
USP35 Acts as a Dual Stabilizer of CDCA8 and PD-L1 to Coordinate the Progression and Immune Evasion in Non-Small Cell Lung Cancer
8天前
已完结
Ablation of ASF1B mitigates the proliferation of A549 cells and enhances anti-PD-L1 therapy by regulating ferroptosis
8天前
已完结
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
1个月前
已关闭
Bispecific dendritic-T cell engager potentiates anti-tumor immunity
1个月前
已完结
Priming of tumor spheroids with IFN-gamma increases efficacy of T cell mediated killing with PD-1 blockade
1个月前
已完结
皖公网安备34019202002308
